Mexiletine demonstrates significantly greater selectivity for depolarized myocardium than quinidine, which may have implications for its proarrhythmic potential.
No takes yet. Share an insight, caveat, or question.
Supports greater mexiletine selectivity than quinidine in hyperkalaemia; leaves open clinical relevance for proarrhythmic risk.
Wyse et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: